Bispecific antibodies are recognized as artificial protein where two or more antigen recognizing elements are combining together to form a single construct. Bispecific antibodies are able to bind into two or more targets at a time. Moreover, these antibodies might bridge two targets together and are able to present high chances of gaining therapeutic effects (bring cancer cell within striking distance). The various formats of bispecific antibodies include quadromas, chemical heteroconjugates, bispecific antibodies with special heterodimeriza-tion domains and bispecific antibodies of minimal size. Bispecific antibodies are primarily utilized for the treatment of cancer and are emerging as a novel technology for dual targeting strategies within one molecule for cancer treatment. Bispecific antibodies improve and ensure the following factors in a cancer targeting agent: increase binding ability, improve selectivity and efficacy. It has observed that bispecific antibodies provide improved efficacy for cancer treatment as compared with combination therapy of other two antibodies. Recombinant DNA technology is identified as the backbone of rapid expansion of bispecific antibody formats.

Bispecific antibodies are evolving a the most preferred and efficient method of treatment for various cancer such as breast, lung, prostate and colon cancer. With rising prevalence of different types of cancer (lung cancer, breast cancer and cervical cancer) the global market for bispecific antibodies treatment is significantly increasing. The World Health Organization (WHO) published in 2014, that worldwide 8.2 million people died of cancer in 2012. Likewise, American Cancer Society (ACS) published that, around 300,000 men and 276,000 women died due to cancer in 2012 in the U.S. Moreover, it is observed that of every six U.S. men have received a diagnosis test for prostate cancer at some point in their lives stated by California Journal of Clinical Cancer (CJCC). However, technical complexity associated with the treatment procedure (detection) of bispecific antibodies would hinder the global market demand of bispecific antibodies treatment during the study period.

North America and Europe were observed to be the largest bispecific antibodies treatment market due to major market players are based in these regions. Moreover, it has observed that the highest numbers of various cancers (lung cancer, prostate cancer, breast cancer and cervical cancer) diagnosis cases are recorded from North America and Europe every year. In addition, favorable initiatives taken by the federal government also would be accounted for the market growth of bispecific antibodies treatment in North American and European regions. Similarly, Asia-Pacific is considered as an untapped market in bispecific antibodies treatment due to lack of proper healthcare facilities in some Asian countries. Asian market growth will be fuelled by the presence of untapped opportunities due to extensive increase in the healthcare infrastructure (healthcare cost, healthcare facility and health care budget). Similarly, Asia-Pacific is considered as an emerging market in bispecific antibodies treatment due to growing market penetration in this region. The rest of the world (RoW) holds fourth position in the global bispecific antibodies treatment market due to poor economic and health condition in most of the African countries.  It has also observed that bispecific antibodies market growth in RoW will be fuelled primarily by extensive increase in healthcare infrastructure in Brazil and Mexico.  

Some of the major players operating in the bispecific antibodies treatment market includes AbbVie, Celgene, Ganymed Pharmaceuticals, Janssen Biotech, OncoMed Pharmaceuticals, Paktis Antibody Services GmbH, Fabion Pharmaceuticals among others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Bispecific Antibodies Market

Pre Book